Page last updated: 2024-12-07

griseolic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

griseolic acid: from Streptomyces griseoaurantiacus SANK 63479; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID127607
MeSH IDM0134673

Synonyms (12)

Synonym
griseolic acid
alpha-l-talo-oct-4-enofuranuronic acid, 1-(6-amino-9h-purin-9-yl)-3,6-anhydro-6-c-carboxy-1,5-dideoxy-
griseolic acid a
79030-08-3
jl8zd6u3ja ,
unii-jl8zd6u3ja
2-(6-aminopurin-9-yl)-5-[carboxy(hydroxy)methyl]-3-hydroxy-3,3a-dihydro-2h-furo[3,2-b]furan-5-carboxylic acid
DTXSID701000208
9-(3,6-anhydro-6-carboxy-5-deoxyoct-4-enofuranuronosyl)-9h-purin-6-amine
.alpha.-l-talo-oct-4-enofuranuronic acid, 1-(6-amino-9h-purin-9-yl)-3,6-anhydro-6-c-carboxy-1,5-dideoxy-
1-(6-amino-9h-purin-9-yl)-3,6-anhydro-6-c-carboxy-1,5-dideoxy-.alpha.-l-talo-oct-4-enofuranuronic acid
AKOS040746866

Research Excerpts

Overview

Griseolic acid (GA) is a potent cyclic AMP (cAMP) phosphodiesterase (PDE) inhibitor. GA has an adenine base and two carboxyl groups in its molecule.

ExcerptReferenceRelevance
"Griseolic acid (GA) is a potent cyclic AMP (cAMP) phosphodiesterase (PDE) inhibitor that has an adenine base and two carboxyl groups in its molecule (Nakagawa F, Okazaki T, Naito A, Iijima Y and Yamazaki M, J Antibiot 38: 823-829, 1985). "( Properties of base-substituted and carboxyl-esterified analogues of griseolic acid, a potent cAMP phosphodiesterase inhibitor.
Iijima, Y; Kaneko, M; Yamazaki, M; Yasumoto, T, 1992
)
1.96

Effects

ExcerptReferenceRelevance
"Griseolic acid has an adenine moiety and two carboxyl groups and possesses the molecular formula C14H13N5O8."( Griseolic acid, an inhibitor of cyclic adenosine 3',5'-monophosphate phosphodiesterase. I. Taxonomy, isolation and characterization.
Iijima, Y; Naito, A; Nakagawa, F; Okazaki, T; Yamazaki, M, 1985
)
2.43
"Griseolic acid has an adenine moiety and two carboxyl groups and possesses the molecular formula C14H13N5O8."( Griseolic acid, an inhibitor of cyclic adenosine 3',5'-monophosphate phosphodiesterase. I. Taxonomy, isolation and characterization.
Iijima, Y; Naito, A; Nakagawa, F; Okazaki, T; Yamazaki, M, 1985
)
2.43

Treatment

ExcerptReferenceRelevance
"Treatment of griseolic acid with HCl-MeOH gave adenine and pseudo-sugar."( Griseolic acid, an inhibitor of cyclic adenosine 3',5'-monophosphate phosphodiesterase. II. The structure of griseolic acid.
Furukawa, Y; Kawazoe, K; Naito, A; Nakagawa, F; Sato, S; Takahashi, S; Tamura, C, 1985
)
2.06
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (42.11)18.7374
1990's10 (52.63)18.2507
2000's1 (5.26)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.22 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.22 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]